We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Visonic | VSC | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
98.50 |
Top Posts |
---|
Posted at 07/9/2009 11:10 by investinggarden Hold recommendation from Growth Company Investor |
Posted at 07/8/2009 18:13 by 29palms Did say that this was one that not a lot of investors were watching.19% increase in my small holding today is good news indeed. DYOR |
Posted at 06/9/2006 11:05 by pugugly robbie12:> Suspect still further to drop - Growth not as fast as some investors were expecting - general worry about geo political problems and the chairman's 67% stake.Cash is nice support but machinery is very quickly out of date in this type of industry. |
Posted at 27/2/2006 11:16 by papalpower February 27, 2006.Visonic expands into the Telemedicine market with New Strategic Alliance Visonic (LSE: VSC), the international developer and manufacturer of electronic security systems (alarms) and home management systems, announces it has significantly strengthened its position in the home healthcare market by entering the rapidly growing telemedicine sector through a strategic partnership agreement with TMT Telemedicine Web Medical Centre (TMT). The agreement signed with the controlling shareholders of TMT, establishes a partnership between Visonic and TMT, within the framework of a company called Visonic -TMT Telemedicine SA, (with head offices in Lyon, France). In exchange for an investment of Euro 711,366, Visonic has gained a stake of 12.15% in the newly formed company. This alliance will give Visonic an enhanced marketing and sales platform with which to expand into the telemedicine field, on the basis of TMT's unique and comprehensive package of solutions in the area of home healthcare and telemedicine. TMT was founded in 2003 in Lyon France, in order to develop service solutions for home care, based on advanced telemedicine technologies. The founders are experienced professionals in the security and medical fields, among them are the former owners of CIPE, a successful French security company, acquired a few years ago by ADT. TMT has successfully formed a package of solutions, including wireless devices for remote medical testing, secured transmission and processing of medical data. TMT has already started to sell its system in France. The system which will be used in Visonic-TMT's telemedicine product offering is the next generation of Visonic's Amber Home Healthcare system, which will use bluetooth technology to communicate with an array of wireless diagnostic equipment. The Amber's ease-of-use is field proven and ideally suited for the elderly and disabled at home, who are Visonic-TMT's target market. Visonic -TMT markets include local government, insurance, service providers and healthcare professionals worldwide. Commenting, Dr. Avi Shachrai, CEO and President of Visonic, said: 'We are extremely pleased to have forged a partnership with TMT and to have established this joint company. Home Healthcare is one of the pillars of our growth strategy and the TMT telemedicine platform will broaden our home healthcare capabilities and enable us to offer comprehensive solutions to a growing market.' Commenting, Mr. Jean Claude Bensoussan, Chairman of the Board of Visonic-TMT said: 'TMT sees in the contribution of Visonic's advanced technologies and strong production capabilities as a major milestone in its growth strategy. Visonic TMT is already in contact with governments, major telemedicine and home healthcare service providers worldwide. Once these contacts mature, management hopes it may have a significant impact on the company's growth.' CONTACT: Dr Avi Shachrai (President & CEO) Shmuel Koren (CFO) Ruth Grossman (Director of Investor Relations) Visonic Tel: + 972 3 645 6718 Email: rutig@visonic.com |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions